Fortis Healthcare Limited organized the Fortis Cancer Summit 2026 to discuss the future of oncology and patient-centric care [1].

The event marks a shift toward personalized medicine, aiming to move beyond standard survival statistics to improve long-term outcomes for cancer patients [2].

The two-day conference [3] took place from May 2 to May 3, 2026 [4]. While some reports identified the location as New Delhi [5], other accounts placed the event in Gurugram [6]. The summit operated under the theme “Beyond Evidence, Based Oncology” [7].

Participants included oncologists, scientists, investors, and patient advocates from over 25 countries [1]. These leading voices gathered to share diverse clinical experiences and foster global collaboration in the fight against cancer [1].

The summit focused on innovative treatment strategies that prioritize the individual needs of the patient. By integrating personalized approaches, the organizers said the goal is to bolster cancer care through a more nuanced understanding of patient health [6].

This international gathering sought to bridge the gap between evidence-based clinical trials and the practical, personalized application of those findings in a clinical setting [2]. The collaboration between the 25-plus nations [1] aimed to create a united front in transforming how oncology is practiced globally [1].

“The summit operated under the theme “Beyond Evidence, Based Oncology”.”

The transition toward 'personalized oncology' represents a broader movement in medicine to move away from one-size-fits-all treatment protocols. By focusing on individual patient data and diverse clinical experiences across 25 countries, healthcare providers are attempting to increase the precision of cancer therapies, which may reduce systemic side effects and improve the quality of life for survivors.